The FDA has launched a salvo at branded television advertising by trying to officially change the adequate provision rule, which allows for alternative means of risk disclosure. Eliminating adequate provision would force the full disclosure of all risks and side effects included in the approved label. This would effectively eliminate the ability to run […]
Getting a patient diagnosed and prescribed is hard. Keeping them on therapy long enough to see real benefit? That’s often even harder — and the stakes couldn’t be higher. Most medications don’t deliver their full effect after a single fill. Antidepressants require weeks of consistent use before therapeutic stabilization sets in. Biologics for chronic skin […]
Pharma’s next growth market isn’t a new drug. It’s an underserved audience. For decades, pharmaceutical marketing has prioritized scale over specificity, relying on broad campaigns designed to reach the “general market.” But as the United States becomes more diverse and patient expectations evolve, that definition no longer reflects reality. Today, growth in healthcare is being […]
Pharmaceutical direct-to-consumer (DTC) marketing has grown increasingly complex. Today’s patients and caregivers don’t engage with brands in a straight line; they move seamlessly between streaming platforms, social media, search engines, display ads, and even offline channels. From their perspective, it’s one continuous experience—not a collection of separate campaigns. Yet many pharma marketers still build and […]
